Significados de invasive candidiasis en inglés

The rule may identify patients at high risk of invasive candidiasis.

The rAls1p-N vaccine is a promising candidate for the prevention of invasive candidiasis.

Hospital-based diagnostic tests need optimising to improve outcomes in patients with suspected invasive candidiasis.

Summary: This knowledge provides the basis of exploring new treatment options in the fight against invasive candidiasis.

Some important advances in the diagnosis of invasive candidiasis include rapid species identification and improvements in antigen testing.

The term " invasive candidiasis" encompasses a group of infections of increasing relevance in the intensive care setting.

Candidaemia is the most common clinical presentation of invasive candidiasis and is a major cause of morbidity and mortality.

Candiduria occurring in critically ill patients should initially be regarded as a marker for the possibility of invasive candidiasis.

Conclusions: The oral ibrexafungerp dose estimated to achieve the target exposure in subjects with invasive candidiasis is 750 mg daily.

Robust pharmacodynamic indices that align fluconazole dose or exposure with outcomes in invasive candidiasis due to Candida glabrata remain elusive.

Conclusions: Treatment of invasive candidiasis in ICU patients requires a broad range of knowledge and skills as summarized in our recommendations.

Echinocandins are employed as the first-line treatment for invasive candidiasis until the fungal species is determined and confirmed by clinical diagnosis.

Background: Invasive candidiasis is an important cause of morbidity and mortality among patients with health care-associated infection.

Invasive candidiasis is an infection that occurs when the Candida species of fungus enters the bloodstream, where it can then spread throughout the body.